Ams Osram Secures €1bn Bond to Halve Financing Costs as €570m Infineon Sale Hangs in Regulatory Balance
24.06.2026 - 03:15:47 | boerse-global.de
The optics and semiconductor group Ams Osram is forging ahead with a balance sheet overhaul long before its biggest near-term catalyst lands. On the refinancing front, the company has already placed a €1bn bond carrying a 7.25% coupon and maturing in May 2032. Proceeds will retire a dollar-denominated note yielding 12.25% in full and part of a euro tranche paying 10.50%, locking in annual interest savings of roughly €40 million from 2027 onwards. The ultimate target is to compress total financing costs from as much as €300 million today to under €150 million by 2028 — a near-halving that would fundamentally reshape the company’s cost profile.
Shareholders have had a wild ride while management pushes the debt agenda. The stock has surged 134% since the start of the year and touched €19.95 in recent trading, though the past thirty days have been messy. A weak sector readout out of Asia prompted profit-taking and valuation concerns across the chip space, dragging Ams Osram down by roughly a quarter over that stretch. On Tuesday alone, the shares lost around 6% to €19.90, despite no negative company-specific news. The annualised volatility of 96% tells the story: every restructuring update moves the price dramatically, and the next big swing is likely to come from Berlin.
The most powerful single lever in the deleveraging plan is the sale of the non-optical sensor business to Infineon for €570 million in cash. Germany’s Federal Cartel Office has been reviewing the transaction since 3 March 2026 and is expected to deliver a verdict before the end of the current quarter. The deal covers products, intellectual property, and test and laboratory equipment — but not manufacturing facilities — and includes a multi-year supply agreement. If approved, Ams Osram’s leverage ratio would drop from 3.3 to roughly 2.5, a structural improvement that would ease the debt burden the company has carried for years.
Should investors sell immediately? Or is it worth buying Ams Osram?
Operationally, the core semiconductor business is holding up. First-quarter 2026 revenue came in at €796 million with an adjusted EBITDA margin of 16.5%, while the semiconductor division posted 9% organic growth year-on-year. Management sees second-quarter revenue landing between €725 million and €825 million and an adjusted EBITDA margin around 15.5%. For the full year, free cash flow is forecast to exceed €300 million.
Analysts are turning increasingly upbeat as the photonics pivot gains credibility. JPMorgan lifted its price target to 23.60 francs and upgraded the stock to Overweight, arguing the opportunities in AI-related photonics are larger and more tangible than previously assumed. Jefferies also raised its rating to Buy with a 21-franc target, citing the same photonics catalyst. Over the medium term, Ams Osram is developing optical interconnects for AI data centres and components for augmented-reality glasses — a category where the company sees value-add of €50 to €100 per device. CFO Rainer Irle has warned, however, that meaningful AI revenue is unlikely before 2030, tempering expectations around the near-term payoff.
For now, the inflection point remains the antitrust decision. Should the regulator wave the Infineon deal through, the €570 million will flow directly into balance-sheet repair and accelerate the refinancing math already underway. Until that verdict arrives, Ams Osram shares will continue to trade on headlines — and the next one could be the most consequential yet.
Ad
Ams Osram Stock: New Analysis - 24 June
Fresh Ams Osram information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
